The American Pharmacists Association (APhA) Foundation has announced it will play a significant role in the new multi-million dollar initiative that we reported on last week. The initiative, called Together on Diabetes, which is being funded by the Bristol-Meyers Squibb Foundatio, will be the biggest-ever corporate philanthropic scheme to combat diabetes in the US.
The APhA Foundation has been picked as an initial partner to help adapt and expand the care model that has already successfully been used in other diabetes schemes, such as the Patient Self-Management Program for Diabetes, the Asheville Project and the Diabetes Ten City Challenge.
The APhA Foundation also has another new diabetes project underway, Project IMPACT: Diabetes, IMProving America’s Communities Together, in which they integrate pharmacists into the healthcare team to help people with diabetes in the challenges they face.
Benjamin Bluml, vice president for research at the APhA Foundatio, said “It is estimated that there are 23.6 million people living with diabetes in the US and another 57 million with pre-diabetes.”
He added “Project IMPACT: Diabetes presents a unique opportunity to connect more patients to an inter-disciplinary health care team with a whole person orientation within the context of their community. Working with the ‘Together on Diabetes’ initiative and our national partners, we look forward to creating a meaningful framework for getting more evidence-based diabetes care to the people who need it the most!”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.